| NDC Code | 49281-181-25 |
|---|
| Package Description | 10 SYRINGE, GLASS in 1 PACKAGE (49281-181-25) > .25 mL in 1 SYRINGE, GLASS (49281-181-00) |
|---|
| Product NDC | 49281-181 |
|---|
| Product Type Name | VACCINE |
|---|
| Proprietary Name | Fluzone Quadrivalent Southern Hemisphere |
|---|
| Non-Proprietary Name | Influenza A Virus A/brisbane/02/2018 Ivr-190 (h1n1) Antigen (formaldehyde Inactivated), Influenza A Virus A/south Australia/34/2019 Ivr-197 (h3n2) Antigen (formaldehyde Inactivated), Influenza B Virus B/phuket/3073/2013 Antigen (formaldehyde Inactivated), And Influenza B Virus B/washington/02/2019 Antigen (formaldehyde Inactivated) |
|---|
| Dosage Form | INJECTION, SUSPENSION |
|---|
| Usage | INTRAMUSCULAR |
|---|
| Start Marketing Date | 20190930 |
|---|
| End Marketing Date | 20201231 |
|---|
| Marketing Category Name | BLA |
|---|
| Application Number | BLA103914 |
|---|
| Manufacturer | Sanofi Pasteur Inc. |
|---|
| Substance Name | INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/SOUTH AUSTRALIA/34/2019 IVR-197 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED) |
|---|
| Strength | 7.5; 7.5; 7.5; 7.5 |
|---|
| Strength Unit | ug/.25mL; ug/.25mL; ug/.25mL; ug/.25mL |
|---|